ROYCE & ASSOCIATES LP - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 77 filers reported holding UTAH MED PRODS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$2,813,576
-7.6%
32,716
+0.1%
0.03%
-3.3%
Q2 2023$3,044,564
-1.6%
32,667
+0.0%
0.03%
-3.2%
Q1 2023$3,095,093
+2.8%
32,659
+9.0%
0.03%
-3.1%
Q4 2022$3,012,180
+10.4%
29,963
-6.3%
0.03%
+3.2%
Q3 2022$2,728,000
-0.5%
31,980
+0.2%
0.03%
+10.7%
Q2 2022$2,741,000
-4.3%
31,906
+0.2%
0.03%
+16.7%
Q1 2022$2,863,000
-9.9%
31,858
+0.2%
0.02%0.0%
Q4 2021$3,178,000
+7.7%
31,784
-0.0%
0.02%
+9.1%
Q3 2021$2,951,000
+9.0%
31,789
-0.2%
0.02%
+15.8%
Q2 2021$2,708,000
-1.8%
31,840
-0.0%
0.02%0.0%
Q1 2021$2,758,000
+3.2%
31,845
+0.4%
0.02%
-13.6%
Q4 2020$2,673,000
+0.3%
31,708
-4.9%
0.02%
-24.1%
Q3 2020$2,664,000
-9.7%
33,353
+0.2%
0.03%
-12.1%
Q2 2020$2,951,000
-5.7%
33,298
+0.0%
0.03%
-23.3%
Q1 2020$3,131,000
-12.8%
33,295
+0.0%
0.04%
+34.4%
Q4 2019$3,592,000
+12.5%
33,286
-0.1%
0.03%
+6.7%
Q3 2019$3,193,000
+0.3%
33,318
+0.2%
0.03%
+3.4%
Q2 2019$3,182,000
+8.5%
33,247
+0.0%
0.03%
+16.0%
Q1 2019$2,934,000
+6.4%
33,245
+0.2%
0.02%0.0%
Q4 2018$2,757,000
-11.9%
33,186
-0.1%
0.02%
+13.6%
Q3 2018$3,128,000
-16.7%
33,204
-2.7%
0.02%
-15.4%
Q2 2018$3,757,000
+11.5%
34,111
+0.1%
0.03%
+8.3%
Q1 2018$3,368,000
+21.4%
34,073
-0.0%
0.02%
+33.3%
Q4 2017$2,775,000
+10.7%
34,088
+0.0%
0.02%
+5.9%
Q3 2017$2,507,000
-4.3%
34,087
-5.8%
0.02%0.0%
Q2 2017$2,621,000
+16.2%
36,2000.0%0.02%
+13.3%
Q1 2017$2,255,000
-14.4%
36,2000.0%0.02%
-11.8%
Q4 2016$2,634,000
+21.7%
36,2000.0%0.02%
+21.4%
Q3 2016$2,165,000
-9.8%
36,200
-5.0%
0.01%
-12.5%
Q2 2016$2,400,000
+0.7%
38,1000.0%0.02%
+6.7%
Q1 2016$2,383,000
+6.9%
38,1000.0%0.02%
+15.4%
Q4 2015$2,230,000
+1.0%
38,100
-7.1%
0.01%
+8.3%
Q3 2015$2,209,000
-9.7%
41,0000.0%0.01%
+20.0%
Q2 2015$2,445,000
-0.4%
41,0000.0%0.01%
+11.1%
Q1 2015$2,454,000
+1.9%
41,000
+2.2%
0.01%
+12.5%
Q4 2014$2,408,000
+11.5%
40,100
-9.5%
0.01%
+14.3%
Q3 2014$2,160,000
-4.8%
44,300
+0.5%
0.01%0.0%
Q2 2014$2,269,000
-9.8%
44,100
+1.4%
0.01%0.0%
Q1 2014$2,516,000
+4.1%
43,500
+2.8%
0.01%0.0%
Q4 2013$2,418,000
-3.8%
42,3000.0%0.01%0.0%
Q3 2013$2,514,000
+9.4%
42,3000.0%0.01%0.0%
Q2 2013$2,297,00042,3000.01%
Other shareholders
UTAH MED PRODS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Penn Mutual Asset Management, LLC 30,283$2,822,3762.54%
Clean Yield Group 30,703$2,861,5201.18%
RICE HALL JAMES & ASSOCIATES, LLC 112,999$10,531,4680.60%
Ranger Investment Management 78,681$7,333,0690.44%
Watershed Asset Management, L.L.C. 2,515$234,3980.29%
ISTHMUS PARTNERS, LLC 20,937$1,951,3280.27%
Cardinal Capital Management 11,309$1,057,3250.21%
GLOBEFLEX CAPITAL L P 9,338$870,3020.10%
Penobscot Investment Management Company, Inc. 4,000$372,8000.06%
JAMES INVESTMENT RESEARCH INC 4,292$400,0140.05%
View complete list of UTAH MED PRODS INC shareholders